EcoDrugPlus

Proteasome 26s Subunit, Non-Atpase 12

Ensembl ID : ENSDLAG00005018025
Gene Symbol: PSMD12
1 Cross references
222 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 14

Ensembl ID : ENSDLAG00005016166
Gene Symbol: PSMD14
1 Cross references
215 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 8

Ensembl ID : ENSDLAG00005031438
Gene Symbol: PSMD8
1 Cross references
213 Possible Orthologues:

Protein Arginine Methyltransferase 5

Ensembl ID : ENSDLAG00005018348
Gene Symbol: PRMT5
1 Cross references
199 Possible Orthologues:

Protein Kinase C Alpha

Ensembl ID : ENSDLAG00005018491
Gene Symbol: PRKCA
1 Cross references
212 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSDLAG00005026189
Gene Symbol: PRKCB
1 Cross references
213 Possible Orthologues:

Protein Kinase C, Beta A

Ensembl ID : ENSDLAG00005025765
Gene Symbol: PRKCBA
1 Cross references
205 Possible Orthologues:

Protein Kinase C, Eta, A

Ensembl ID : ENSDLAG00005015275
Gene Symbol: PRKCHA
1 Cross references
223 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSDLAG00005013799
Gene Symbol: PRKD3
1 Cross references
207 Possible Orthologues:

Protein Tyrosine Kinase 2 Beta, B

Ensembl ID : ENSDLAG00005010190
Gene Symbol: PTK2BB
1 Cross references
196 Possible Orthologues:

Protein Tyrosine Phosphatase Non-Receptor Type 11a

Ensembl ID : ENSDLAG00005010624
Gene Symbol: PTPN11A
1 Cross references
253 Possible Orthologues:

Protein Tyrosine Phosphatase Receptor Type B

Ensembl ID : ENSDLAG00005002586
Gene Symbol: PTPRB
1 Cross references
193 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).